Pathogenics, Inc. Licenses Worldwide Rights to Novel Anti-Infective Compound for Ophthalmological Use HINGHAM, Mass., April 19, 2006 (PRIMEZONE) -- Pathogenics, Inc. (Other OTC:PTGN) today announced that it has licensed to Acuity Pharmaceuticals, Inc. the exclusive worldwide rights to N-Chlorotaurine,...